Evidence map›Paper›PMID 40809053›Full record

ReviewFrontiers in microbiology2025

Gut microbiota in gastric cancer: from pathogenesis to precision medicine.

Shuang Huo, Kaiying Lv, Lutuo Han, Yu Zhao, Jiakang Jiang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Advances inOncology letters · 2026
    Review
  2. Review
  3. Revisiting multi-region 16S sequencing in gastric cancer.World journal of gastrointestinal oncology · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuang Huo *Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
Kaiying Lv *Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
Lutuo HanGraduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
Yu ZhaoGraduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
Jiakang JiangDepartment of Oncology, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) remains a significant global health burden, driven by a complex interplay of genetic, environmental, and microbial factors. Emerging evidence highlights the critical role of gut microbiota in gastric carcinogenesis, as microbial dysbiosis disrupts gastrointestinal homeostasis, fuels chronic inflammation, and promotes immunomodulation and metabolic reprogramming.

Indexed as

dysbiosisgastric cancergut microbiotaHelicobacter pyloriinflammationtumor microenvironment

Identifiers

PMID40809053
PMCPMC12344422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.